Currently, there are 23 cases registered in the country, a growth mirrored by the increase in cases in the EU (13,045 as of 26 July). While the government advises citizens to avoid risky situations--such as intimate contact with the infected--the ministry on Friday also highlighted that 1,400 doses of a vaccine by Danish vaccine manufacturer Bavarian Nordic would arrive in the country in August.
The smallpox vaccine has been approved as effective protection against the virus.
The European Health Emergency Preparedness and Response Authority (Hera) ordered a total of 109,000 doses.
While the Luxembourg government has in the past stated that the most vulnerable would have priority when it came to inoculation with the smallpox vaccine, the superior council for infectious diseases (CSMI) said it was currently working on a list of prioritised patients.
Most cases found in Europe were in patients between 31 and 40 years old. In Luxembourg, all cases recorded are men with an average of 39 years old, the ministry stated. Of the EU cases whose HIV status was known, 37% were HIV positive. The majority of cases presented with a rash and symptoms such as fever, fatigue, muscle pain, vomiting, diarrhoea, chills, sore throat or headache.
So far, no deaths linked to the epidemic in the EU have been recorded.
